Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

16 September 2021: Articles  USA

Cardiomyopathy, Proximal Myopathy, Camptocormia, and Novel Filamin C (FLNC) Variant: A Case Report

Rare coexistence of disease or pathology

Sara Jasmin Hooshmand1AEF*, Raghav Govindarajan1ADE, Brian P. Bostick2DE

DOI: 10.12659/AJCR.932648

Am J Case Rep 2021; 22:e932648

0 Comments

Abstract

BACKGROUND: Filamin C (FLNC) is an actin crosslinking protein that provides structural support for the sarcomere. The exact function of FLNC is unknown; however, mutations have been reported in myopathies and cardiomyopathies, but rarely both. In this paper, we describe a case of adult-onset camptocormia, proximal myopathy, and cardiomyopathy and an intronic FLNC mutation.

CASE REPORT: A 56-year-old man was referred to the neurology clinic for truncal weakness. The patient reported having curvature of his spine, which he said his mother also had prior to her dying suddenly due to a “cardiac issue.” The patient was found to have fatty infiltration of the periscapular and paraspinal muscles. Additionally, electromyography revealed irritable myopathy of the paraspinal muscles, and an echocardiogram revealed an ejection fraction of 40%. A genetic panel conducted through PerkinElmer Genomics revealed a heterozygous mutation c.1210+3A>G in the intron region of FLNC. Due to his low ejection fraction and family history of sudden cardiac death, he received an implantable cardioverter-defibrillator and began carvedilol. The patient received physical therapy for camptocormia.

CONCLUSIONS: The variability in genotypic-phenotypic relationships of FLNC mutations is a growing area of research. It is important to increase awareness to further the development of gene-targeted therapies. We hope this unique clinical presentation of co-occurring skeletal and cardiomyopathy secondary to an intronic mutation will increase awareness of the broad phenotypic spectrum of FLNC mutations.

Keywords: Cardiomyopathy, Dilated, FLNC Protein, Human, Adult, Cardiomyopathies, Female, Filamins, Humans, Middle Aged, Muscular Atrophy, Spinal, Muscular Diseases, Mutation, spinal curvatures

Background

Filamin C is a protein encoded by the FLNC gene. This actin crosslinking structural protein has a role in anchoring cells to the extracellular matrix and is involved in signaling pathways [1,2]. FLNC is primary expressed in skeletal and cardiac muscle. Variants of FLNC mutations were originally described in cases of skeletal myopathies, and, more recently, specific variants have been described in cases of isolated, familial cardiomyopathies [3–9].

This paper describes a case of dilated cardiomyopathy, proximal myopathy with camptocormia, and an intronic mutation of the FLNC gene. Although there have been many reports of FLNC-associated cardiac and skeletal myopathies, it is less common to see cardiac and skeletal involvement co-occurring in a single individual [10]. Our case adds to the growing literature of the variability in the genotypic-phenotypic relationship of FLNC mutation.

Case Report

A 56-year-old man presented after being evaluated by the orthopedic surgery department for right hip pain. Upon evaluation, the patient was incidentally found to have atrophy of his back and truncal weakness, which resulted in a referral to the neurology clinic. He had a history of osteoarthritis, hyper-tension, diabetes, and obstructive sleep apnea. He was treated with amlodipine and hydrochlorothiazide for hypertension and metformin for diabetes. He was poorly compliant with his continuous positive airway pressure due to fear of acquiring an infection. He reported chewing tobacco, rarely drinking alcohol, and working full time in the steel industry.

He reported his mother had developed similar spine curvature and died suddenly at age 66 from a “cardiac problem.” The patient’s brother had an aortic dissection at the age of 40 and underwent a surgical repair. There was no genetic testing of his family members or any known skeletal or cardiac myopathies to the patient’s knowledge.

The patient reported noticing muscular weakness in his chest and upper back, causing him to walk with an abnormal posture for the past 6 years. Despite his posture, he reported being able to continue performing physical activities in the steel industry with minimal limitations. The patient denied any palpitations, lightheadedness, syncope, chest pain, dyspnea, and paroxysmal nocturnal dyspnea upon evaluation.

The patient’s mental status examination was intact, the patient’s language was comprehensible with fluency intact, and no hypophonia was present. The patient’s physical examination was notable for significant flexion of the thoracolumbar spine on upright posture, which resolved in the supine position. There was atrophy of the pectoralis, paravertebral, and hip muscles. The patient had normal musculature of his extremities. Cranial nerves were intact, except for cranial nerve XI, which was grade 3 of 5 for strength bilaterally. Hip flexion, knee flexion, and knee extensor were MRC grade 4 of 5 bilaterally. The patient’s reflexes were 2+ bilaterally throughout the examination. The patient was unable to perform tandem gait. There was palmoplantar keratoderma on his hands.

There was no elevation of creatinine kinase at 0.70 mg/dL (reference range, 0.70–1.20 mg/dL). The patient underwent magnetic resonance imaging (MRI) of the cervical, thoracic, and lumbar spine, which revealed asymmetrical fatty infiltration of the periscapular and paraspinal muscles (Figure 1A, 1B). Electromyography showed irritable myopathy in the paraspinal muscles with early recruitment in the deltoid, biceps, and hip flexors. Echocardiogram revealed a left ventricular ejection fraction of 40% with akinesis in the inferior basilar septal segment. The cardiac MRI revealed biventricular dilation with reduced systolic function. There was severe hypokinesis of the basal inferoseptum and inferolateral wall, with late gadolinium enhancement suggestive of nonspecific fibrosis (Figure 1C). An electrocardiogram showed sinus rhythm and left anterior fascicular block. A coronary angiography showed nonobstructive coronary artery disease. The patient underwent Holter monitoring, which revealed 9% premature ventricular contractions. The pulmonary function test revealed a forced vital capacity (FVC) of 40% predicted. He was started on a Trilogy ventilator.

A genetic panel conducted through PerkinElmer Genomics revealed a heterozygous mutation c.1210+3A>G in the intron region 7 of FLNC (Figure 2). A FSHD1 Southern blot test (Quest Diagnostics) was negative. A muscle biopsy was deferred due to higher risk of cardiopulmonary complications given his low ejection fraction and low FVC.

The patient was referred to the physical medicine and rehabilitation departments for his camptocormia. Our patient’s heart failure was New York Heart Association class I. Given his family history of sudden cardiac death and the presence of a FLNC mutation, he received a single-chamber implantable cardioverter-defibrillator placement for primary prevention. He was also started on carvedilol 12.5 mg twice daily.

Discussion

Filamin C, encoded by the FLNC gene, is an emerging cause of cardiac or skeletal myopathies [3–9]. Previous studies demonstrated the effect of FLNC splice-site mutations on sarcomere structures [3–12]. However, these mutations phenotypically presented as isolated cases of cardiomyopathy [3–9]. Our patient’s co-occurring skeletal and cardiac myopathy, possible familial involvement, and genomic evidence supports a mechanism of a novel intronic FLNC splice-site mutation.

While we cannot be certain of the effect the FLNC mutation (c. 1210+3A>G), the substitution of A with a G3 nucleotide after exon 7 in the intronic region of the ROD1 domain has been shown to disrupt RNA splicing. This can result in a loss of function truncated splice variant that predisposes patients to dilated cardiomyopathy [3]. In addition, splice variants in the ROD1 domain have been associated with proximal myopathies, as seen in our patient, although camptocormia had not been previously described. It remains unclear if camptocormia is a phenotypic presentation of the FLNC variant or is due to another etiology. Clinical, laboratory, and genetic testing have ruled out other causes of camptocormia.

Interestingly, Ortiz-Genga et al noted palmoplantar keratoderma segregation with the cardiac phenotype and FLNC mutations in 4 family members. These unique combination findings were identical to the patient described in our case report [5]. Furthermore, Deo et al investigated the cardiac phenotype in fish and demonstrated FLNC-b knockdown splice-site inhibition resulting in cardiomyopathy with ventricular delay in fish, as was seen in our patient [13].

Our report is limited because we did not have a muscle biopsy analysis to confirm a myofibrillary pattern, although electrodi-agnostic and muscle MRI results confirmed a proximal myopathy. While the patient had a family history of cardiovascular disease, further segregation of this genetic variation was limited by the lack of gene testing among family members, who would not consent for gene testing. This is a common clinical scenario and has been reported in genetic conditions as well [14]. We hope that the distinct clinical, imaging, electro-diagnostic, laboratory, and genetic characterization of this patient will increase awareness of the broad phenotypic spectrum of FLNC mutations and genetic cardiomyopathies.

Conclusions

Variants in FLNC can lead to myopathies and cardiomyopathies. The difference in phenotypes can be partly explained by the pathomechanism and location with the gene. Splice-site changes resulting in truncating variants can lead to a dilated cardiomyopathy with proximal myopathy. We hope this unique clinical presentation of co-occurring proximal myopathy and dilated cardiomyopathy with camptocormia will increase awareness of the broad phenotypic spectrum of FLNC mutations and genetic cardiomyopathies.

References:

1.. Thompson TG, Chan YM, Hack AA, Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein: J Cell Biol, 2000; 148(1); 115-26

2.. Gonzalez-Morales N, Holenka TK, Schock F, Filamin actin-binding and titin-binding fulfill distinct functions in z-disc cohesion: PLoS Genet, 2017; 13(7); e1006880

3.. Verdonschot J, Vanhoutte E, Claes GR, A mutation update for the FLNC gene in myopathies and cardiomyopathies: Hum Mutat, 2020; 41(6); 1091-11

4.. Begay RL, Graw SL, Sinagra G, Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures: JACC Clin Electrophysiol, 2018; 4(4); 504-14

5.. Ortiz-Genga MF, Cuenca S, Dal Ferro M, Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies: J Am Coll Cardiol, 2016; 68(22); 2440-51

6.. Valdés-Mas R, Gutiérrez-Fernández A, Gómez J, Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy: Nat Commun, 2014; 5; 5326

7.. Gómez J, Lorca R, Reguero JR, Screening of the filamin C gene in a large cohort of hypertrophic cardiomyopathy patients: Circ Cardiovasc Genet, 2017; 10; e001584

8.. Janin A, N’Guyen K, Habib G, Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy: Clin Genet, 2017; 92(6); 616-23

9.. Brodehl A, Ferrier RA, Hamilton SJ, FORGE Canada Consortium. Mutations in FLNC are associated with familial restrictive cardiomyopathy: Hum Mutat, 2016; 37; 269-79

10.. Vorgerd M, van der Ven PF, Bruchertseifer V, A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy: Am J Hum Genet, 2005; 77; 297-304

11.. Friedman JH, Episodic camptocormia in PD: Mov Disord, 2001; 16; 1201

12.. Golbus JR, Puckelwartz MJ, Dellefave-Castillo L, Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy: Circ Cardiovasc Genet, 2014; 7; 751-59

13.. Deo RC, Musso G, Tasan M, Prioritizing causal disease genes using unbiased genomic features: Genome Biol, 2014; 15(12); 534

14.. Hoffman-Andrews L, The known unknown: The challenges of genetic variants of uncertain significance in clinical practice: J Law Biosci, 2018; 4(3); 648-57

SARS-CoV-2/COVID-19

29 June 2022 : Case report  USA

A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome

Am J Case Rep In Press; DOI: 10.12659/AJCR.936896  

16 June 2022 : Case report  Ecuador

Multidrug-Resistant Klebsiella pneumoniae in a Patient with SARS-Cov-2 Pneumonia in an Intensive Care Unit ...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936498  

13 June 2022 : Case report  Japan

Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review

Am J Case Rep In Press; DOI: 10.12659/AJCR.936889  

13 June 2022 : Case report  Saudi Arabia

Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19

Am J Case Rep In Press; DOI: 10.12659/AJCR.936128  

In Press

01 Jul 2022 : Case report  Poland

A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Per...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936536  

30 Jun 2022 : Case report  Philippines

Erasmus Syndrome: A Case Report and Literature Review

Am J Case Rep In Press; DOI: 10.12659/AJCR.937061  

30 Jun 2022 : Case report  USA

A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome

Am J Case Rep In Press; DOI: 10.12659/AJCR.936896  

30 Jun 2022 : Case report  China (mainland)

Septic Shock Induced by Acute Pyelonephritis Resulting from Kidney Stones Treated by Double-J Ureteral Sten...

Am J Case Rep In Press; DOI: 10.12659/AJCR.936967  

Most Viewed Current Articles

23 Feb 2022 : Case report  USA

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

17 Feb 2022 : Case report  Oman

Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...

DOI :10.12659/AJCR.934399

Am J Case Rep 2022; 23:e934399

06 Dec 2021 : Case report  Brazil

Lipedema Can Be Treated Non-Surgically: A Report of 5 Cases

DOI :10.12659/AJCR.934406

Am J Case Rep 2021; 22:e934406

09 Feb 2022 : Case report  Saudi Arabia

Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COV...

DOI :10.12659/AJCR.934744

Am J Case Rep 2022; 23:e934744

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923